The Food and Drug Administration (FDA) has issued an order restricting sales and distribution of the contraceptive device Essure. Plus: Can a Pap test one day be used to diagnose ovarian, endometrial cancers?
A 26-year-old G0 comes to the office complaining of dysuria and painful lesions on her vulva. Can you make the correct diagnosis and treatment plan?
A collection of standards, guidelines, tools and articles for further reading on maternal mortality. ACOG guidelines for emergencies and adverse effects; resources for coping with the death of a patient. Plus, news from Haiti about using mobile technology to save mothers.
A family history of uterine cancer prompted the patient to seek a hysterectomy.
Contemporary OB/GYN will post links to reports on OB hospital closures to help illustrate the impact these closures have on their patients and maternal mortality rates. Be sure to check back often for the very latest links and information.
Two physicians recount their experiences of losing a patient.
Dr. James Greenberg gives his review of the LiquiBand Exceed Topical Skin Adhesive.
Readers write in about their thoughts on Contemporary OB/GYN's coverage of the maternal mortality issue, urge the avoidance of politicizing issues, and argue for the reduction of cesarean deliveries.
The U.S. Food and Drug Administration (FDA) has done women a disservice by incompletely examining the evidence for risk and benefits associated with morcellation for women undergoing surgery for suspected fibroids. Of note, within days of the FDA report, the Agency for Healthcare Quality and Research (AHRQ) of the US Department of Health and Human Services published a more rigorous and complete analysis of available data with entirely different results and conclusions. Thirty-six signees recommend that Contemporary OB/GYN’s readers review the AHRQ findings and decide which report serves women best.
The purpose of this article is to review the steps in a cesarean delivery and examine the best available evidence for performing the procedure.